Clinical trial

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

NCT00278070

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention vinorelbine oral formulation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Prostate Cancerverified · MONDO: prostate cancer

Interventions

vinorelbine oral formulationDRUG

Sponsors & collaborators

Hellenic Cooperative Oncology Grouplead sponsor

University of Ioanninacollaborator

Mapped research locations

AthensGreece6 ThessalonikiGreece2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00278070 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.